REGN
Regeneron Pharmaceuticals, Inc.
Stock
$735.20+0.39 (+0.05%)Close Oct 2, 2026
- Net income, 2025
- $4.5B
- YoY, 2025
- +2.1%
- 5-year CAGR
- +5.1%
- 10-year CAGR
- +21.6%
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | $4.5B | +2.1% |
| 2024 | $4.4B | +11.6% |
| 2023 | $4.0B | −8.9% |
| 2022 | $4.3B | −46.3% |
| 2021 | $8.1B | +129.9% |
| 2020 | $3.5B | +66.0% |
| 2019 | $2.1B | −13.4% |
| 2018 | $2.4B | +104.0% |
| 2017 | $1.2B | +33.8% |
| 2016 | $896M | +40.8% |
| 2015 | $636M | +88.1% |
| 2014 | $338M | −18.3% |
| 2013 | $414M | −44.9% |
| 2012 | $750M | — |
| 2011 | −$222M | — |
| 2010 | −$104M | — |
| 2009 | −$68M | — |
| 2008 | −$79M | — |